Source comparison
NAD+ MOTS-C for Metabolic Research: Dosing and Delivery Comparison
NAD+ (via NR or NMN precursor) 250–500mg daily Oral (sublingual for NMN) Room temp, amber glass, dry Restores electron transport chain flux, increases mitochondrial ATP output Morning dose to align with circadian NAD+ biosynthesis peak MOTS-C peptide 5–10mg pe
This comparison does not assign a generated winner or score.
- NAD+ (via NR or NMN precursor)
- 250–500mg daily
- Oral (sublingual for NMN)
- Room temp, amber glass, dry
- Restores electron transport chain flux, increases mitochondrial ATP output
- Morning dose to align with circadian NAD+ biosynthesis peak
- MOTS-C peptide
- 5–10mg per injection, 2–3×/week
- Subcutaneous injection
- −20°C lyophilized; 2–8°C reconstituted, use within 28 days
- Direct AMPK activation, shifts metabolism from glucose storage to fat oxidation
- 30–60 min before exercise or fasted periods for maximum substrate oxidation
- Combined NAD+ MOTS-C protocol
- Both at standard doses, staggered timing
- Oral NAD+ precursor + subQ MOTS-C
- NAD+ room temp; MOTS-C refrigerated
- NAD+ restores capacity; MOTS-C reprograms substrate preference
- NAD+ morning; MOTS-C pre-exercise for AMPK and contractile synergy